High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia

被引:13
|
作者
Haring, Martijn P. D. [1 ]
Peeks, Fabian [2 ]
Oosterveer, Maaike H. [3 ]
Brouwers, Martijn C. G. J. [4 ]
Hollak, Carla E. M. [5 ]
Janssen, Mirian C. H. [6 ]
Langendonk, Janneke G. [7 ]
Rennings, Alexander J. M. [6 ]
Wagenmakers, Margreet A. E. M. [7 ]
Verkade, Henkjan J. [8 ]
Derks, Terry G. J. [2 ]
de Meijer, Vincent E. [1 ,9 ,10 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Metab Dis, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Groningen, Netherlands
[4] Maastricht Univ Med Ctr, Dept Internal Med, Div Endocrinol & Metab Dis, Maastricht, Netherlands
[5] Amsterdam Univ Med Ctr, Univ Amsterdam, Dept Endocrinol & Metab, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[7] Erasmus MC, Univ Med Ctr Rotterdam, Ctr Lysosomal & Metab Dis, Dept Internal Med, Rotterdam, Netherlands
[8] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat,Pediat Gastroenterol & Hepatol, Groningen, Netherlands
[9] Univ Groningen, Hanzepl 1, NL-9700 RB Groningen, Netherlands
[10] Univ Med Ctr Groningen, Hanzepl 1, NL-9700 RB Groningen, Netherlands
基金
荷兰研究理事会;
关键词
Benign neoplasm; Hepatic adenoma; Glycogen storage disease type Ia; Metabolic disorder; Glucose-6-phosphatase triglycerides; FATTY-ACID SYNTHASE; MUTATION ANALYSIS; MANAGEMENT; CLASSIFICATION; GUIDELINES; CARCINOMA; DIAGNOSIS; RISK; GENE; 1A;
D O I
10.1016/j.jhepr.2022.100512
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Glycogen storage disease type Ia (GSDIa) is an inborn error of carbohydrate metabolism caused by pathogenic variants in the glucose-6-phosphatase catalytic subunit 1 (G6PC1) gene and is associated with hepatocellular adenoma (HCA) formation. Data on risk factors for HCA occurrence in GSDIa are scarce. We investigated HCA development in relation to sex, G6PC1 genotype, and serum triglyceride concentration (TG).Methods: An observational study of patients with genetically confirmed GSDIa >-12 years was performed. Patients were categorised for sex; presence of 2, 1, or 0 predicted severe G6PC1 variant (PSV); and median TG during childhood (<12 years; stratified for above/below 5.65 mmol/L, i.e. 500 mg/dl).Results: Fifty-three patients (23 females) were included, of which 26 patients developed HCA at a median (IQR) age of 21 (17-25) years. At the age of 25 years, 48% of females and 30% of males had developed HCA (log-rank p = 0.045). Two-thirds of patients with GSDIa carried 2 PSVs, 20% carried 1, and 13% carried none. Neither the number of PSVs nor any specific G6PC1 variants were associated with HCA occurrence. Childhood TG was 3.4 (3.0-4.2) mmol/L in males vs. 5.6 (4.0-7.9) mmol/L in females (p = 0.026). Childhood TG >5.65 mmol/L was associated with HCA development at younger age, compared with patients with childhood TG <5.65 mmol/L (18 vs. 33 years; log-rank p = 0.001). Cox regression analysis including TG, sex, and TG-sex interaction correction revealed childhood TG >5.65 mmol/L as an independent risk factor for HCA development (hazard ratio [HR] 6.0; 95% CI 1.2-29.8; p = 0.028).onclusions: In patients with GSDIa, high childhood TG was associated with an increased risk of HCA, and earlier onset of HCA development, independent of sex-associated hypertriglyceridaemia, and G6PC1 genotype.Lay summary: Glycogen storage disease type Ia (GSDIa) is a rare, inherited metabolic disease that can be complicated by liver tumours (hepatocellular adenomas), which in turn may cause bleeding or progress to liver cancer. Risk factors associated with hepatocellular adenoma formation in patients with GSDIa are largely unknown. In our study, we found that high serum triglyceride concentrations during childhood, but not specific genetic variants, were associated with increased risk of he-patocellular adenoma diagnosis later in life.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 30 条
  • [1] Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia
    Reddy, Srinevas K.
    Kishnani, Priya S.
    Sullivan, Jennifer A.
    Koeberl, Dwight D.
    Desai, Dev M.
    Skinner, Michael A.
    Rice, Henry E.
    Clary, Bryan M.
    JOURNAL OF HEPATOLOGY, 2007, 47 (05) : 658 - 663
  • [2] Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type I
    Wang, David Q.
    Fiske, Laurie M.
    Carreras, Caroline T.
    Weinstein, David A.
    JOURNAL OF PEDIATRICS, 2011, 159 (03) : 442 - 446
  • [3] Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease
    Kishnani, Priya S.
    Chuang, Tzu-Po
    Bali, Deeksha
    Koeberl, Dwight
    Austin, Stephanie
    Weinstein, David A.
    Murphy, Elaine
    Chen, Ying-Ting
    Boyette, Keri
    Liu, Chu-Hao
    Chen, Yuan-Tsong
    Li, Ling-Hui
    HUMAN MOLECULAR GENETICS, 2009, 18 (24) : 4781 - 4790
  • [4] Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy
    Lee, Young Mok
    Jun, Hyun Sik
    Pan, Chi-Jiunn
    Lin, Su Ru
    Wilson, Lane H.
    Mansfield, Brian C.
    Chou, Janice Y.
    HEPATOLOGY, 2012, 56 (05) : 1719 - 1729
  • [5] A specific serum lipid signature characterizes patients with glycogen storage disease type Ia
    Rossi, Alessandro
    Ruoppolo, Margherita
    Fedele, Roberta
    Pirozzi, Francesca
    Rosano, Carmen
    Auricchio, Renata
    Melis, Daniela
    Strisciuglio, Pietro
    Oosterveer, Maaike H.
    Derks, Terry G. J.
    Parenti, Giancarlo
    Caterino, Marianna
    JOURNAL OF LIPID RESEARCH, 2024, 65 (10)
  • [6] Contrast-Enhanced Ultrasonography in Patients With Glycogen Storage Disease Type Ia and Adenomas
    Nguyen, Anh T.
    Bressenot, Aude
    Manole, Simona
    Galloy, Marie A.
    Bronowicki, Jean P.
    Vidailhet, Michel
    Feillet, Francois
    Claudon, Michel
    JOURNAL OF ULTRASOUND IN MEDICINE, 2009, 28 (04) : 497 - 505
  • [7] Glycogen storage disease type Ia: Linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism
    Sever, Sakine
    Weinstein, David A.
    Wolfsdorf, Joseph I.
    Gedik, Reyhan
    Schaefer, Ernst J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (06) : 596 - 600
  • [8] Glycogen storage disease type Ia: molecular study in Brazilian patients
    Reis, FD
    Caldas, HC
    Norato, DYJ
    Schwartz, IVD
    Giugliani, R
    Burin, MG
    Sartorato, EL
    JOURNAL OF HUMAN GENETICS, 2001, 46 (03) : 146 - 149
  • [9] Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk
    Nagasaka, Hironori
    Hirano, Ken-ichi
    Ohtake, Akira
    Miida, Takashi
    Takatani, Tomozumi
    Murayama, Kei
    Yorifuji, Tohru
    Kobayashi, Kunihiko
    Kanazawa, Masaki
    Ogawa, Atsushi
    Takayanagi, Masaki
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (10) : 1009 - 1016
  • [10] Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia
    Cho, Jun-Ho
    Lee, Young Mok
    Bae, Seong-Ho
    Chou, Janice Y.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (01) : 1 - 7